BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19447156)

  • 21. Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages?
    Capitani E; Cazzaniga R; Francescani A; Spinnler H
    Neurol Sci; 2004 Oct; 25(4):198-204. PubMed ID: 15549505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subscores of the FAB differentiate frontotemporal lobar degeneration from AD.
    Lipton AM; Ohman KA; Womack KB; Hynan LS; Ninman ET; Lacritz LH
    Neurology; 2005 Sep; 65(5):726-31. PubMed ID: 16157906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes.
    Wicklund AH; Rademaker A; Johnson N; Weitner BB; Weintraub S
    Alzheimer Dis Assoc Disord; 2007; 21(4):S70-8. PubMed ID: 18090428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it time to separate subjective cognitive complaints from the diagnosis of mild cognitive impairment?
    Mitchell AJ
    Age Ageing; 2008 Sep; 37(5):497-9. PubMed ID: 18682432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal order memory assessed during spatiotemporal navigation as a behavioral cognitive marker for differential Alzheimer's disease diagnosis.
    Bellassen V; Iglói K; de Souza LC; Dubois B; Rondi-Reig L
    J Neurosci; 2012 Feb; 32(6):1942-52. PubMed ID: 22323707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.
    Stephens S; Kenny RA; Rowan E; Allan L; Kalaria RN; Bradbury M; Ballard CG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1053-7. PubMed ID: 15481073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehension of before and after in frontotemporal degeneration.
    Karjalainen M; Rantala L; Jäntti P; Remes AM
    Logoped Phoniatr Vocol; 2005; 30(1):28-33. PubMed ID: 16040437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of semantic dementia on everyday actions: evidence from an ecological study.
    Bier N; Bottari C; Hudon C; Joubert S; Paquette G; Macoir J
    J Int Neuropsychol Soc; 2013 Feb; 19(2):162-72. PubMed ID: 23157853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined memory and executive function tests can screen mild cognitive impairment and converters to dementia in a community: the Osaki-Tajiri project.
    Nakata E; Kasai M; Kasuya M; Akanuma K; Meguro M; Ishii H; Yamaguchi S; Meguro K
    Neuroepidemiology; 2009; 33(2):103-10. PubMed ID: 19494551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prodromal cognitive signs of dementia in 85-year-olds using four sources of information.
    Sacuiu S; Sjögren M; Johansson B; Gustafson D; Skoog I
    Neurology; 2005 Dec; 65(12):1894-900. PubMed ID: 16380609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief assessment of cognitive mental status in Hebrew: Addenbrooke's Cognitive Examination.
    Newman JP
    Isr Med Assoc J; 2005 Jul; 7(7):451-7. PubMed ID: 16011062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short neuropsychologic and cognitive evaluation of frontotemporal dementia.
    Valverde AH; Jimenez-Escrig A; Gobernado J; Barón M
    Clin Neurol Neurosurg; 2009 Apr; 111(3):251-5. PubMed ID: 19062159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder.
    Braaten AJ; Parsons TD; McCue R; Sellers A; Burns WJ
    Int J Neurosci; 2006 Nov; 116(11):1271-93. PubMed ID: 17000529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment in multiple sclerosis: a longitudinal study.
    Amato MP; Ponziani G; Amaducci L
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():465-8. PubMed ID: 10689495
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic criteria for fronto-temporal lobe degeneration].
    Robert PH; Lafont V; Snowden JS; Lebert F
    Encephale; 1999; 25(6):612-21. PubMed ID: 10668605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of the Wechsler Abbreviated Scale of Intelligence-Second Edition (WASI-II) to the neurocognitive deficits associated with the semantic dementia variant of frontotemporal lobar degeneration: A case study.
    Gontkovsky ST
    Appl Neuropsychol Adult; 2017; 24(3):288-293. PubMed ID: 27101084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onset of terminal decline in cognitive abilities in individuals without dementia.
    Thorvaldsson V; Hofer SM; Berg S; Skoog I; Sacuiu S; Johansson B
    Neurology; 2008 Sep; 71(12):882-7. PubMed ID: 18753475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.